HopeStage
Back to all studies
CompletedNCT06805565

A Study of ONO-1110 in Patients With Social Anxiety Disorder

This study evaluated the safety and effectiveness of ONO-1110 for people with anxiety.

Medication studyAges 18–65Japan
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety and effectiveness of ONO-1110 for people with anxiety.

Who was this study for?

This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Fukuoka and 26 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateStarted: January 31, 2025
Recruitment status
Completed
Enrollment listed in the registry
115
Sponsor
Ono Pharmaceutical Co., Ltd.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Japan
Age range
From 18 Years to 65 Years
Official registry ID
NCT06805565
Official title
Show the full official title

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Social Anxiety Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Fukuoka · Gunma · Hokkaido

6 more locations
  • Hyōgo
  • Kanagawa
  • Miyazaki
  • Osaka
  • Tokushima
  • Tokyo
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety and effectiveness of ONO-1110 for people with anxiety.

Who is behind this study?

The study sponsor is Ono Pharmaceutical Co., Ltd., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including ONO-1110 and Placebo.

Who was this study for?

This study was for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Explore HopeStage studies by mental health topic and refine the results to suit your situation.

Find a study that may fit me